A recent multiplex imaging analysis in melanoma indicated that specific spatial immune patterns, notably the co-localization of CD8+ T-cells with antigen-presenting dendritic cells expressing CD11c, significantly correlate with favorable responses to anti-PD-1 therapy (39, 40). The gene discussed is CD8A; the disease is melanoma.